GO:0006986 response to unfolded protein: Cellular Stress Response, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0006986 response to unfolded protein describes any cellular or organismal change triggered by unfolded protein stress, including gene expression, secretion, and enzyme production.
The unfolded protein response (UPR) is a conserved signaling network that restores proteostasis by halting translation, increasing chaperone production, and enhancing degradation of misfolded proteins.
Three canonical ER stress sensors—PERK, ATF6, and IRE1—initiate the UPR in mammals, while mitochondrial UPR (UPRmt) provides parallel quality control in mitochondria.
Dysregulated unfolded protein responses are implicated in cancer, neurodegeneration, diabetes, and inflammatory diseases, making this pathway a major therapeutic target.
Key effector genes include HSPA5 (BiP), XBP1, ATF4, DDIT3 (CHOP), and HSPA1A, which coordinate adaptation or apoptosis depending on stress intensity.
CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of UPR gene function in disease and drug discovery.

Description

The response to unfolded protein (GO:0006986) is a fundamental biological process that cells activate when they detect an accumulation of improperly folded proteins. This response encompasses changes in gene expression, protein synthesis, secretion, and degradation that collectively aim to restore protein homeostasis, or proteostasis. First characterized in yeast and later extended to mammals, the unfolded protein response (UPR) is now recognized as a central node in cellular stress biology. The endoplasmic reticulum (ER) is the primary site where secretory and membrane proteins fold; when this capacity is overwhelmed, ER stress sensors trigger a coordinated transcriptional and translational program. The importance of GO:0006986 extends beyond basic cell biology. In cancer, tumor cells exploit the UPR to survive hypoxia and nutrient deprivation, while in neurodegeneration, chronic UPR activation contributes to neuronal death. Mitochondria also mount a distinct unfolded protein response (UPRmt) that communicates with the ER UPR to manage proteotoxic stress. Understanding the molecular players and regulatory logic of this response is essential for developing therapies that target protein misfolding diseases. This article provides a research-grade overview of GO:0006986, covering its definition, core mechanisms, key genes, disease relevance, and experimental models including CRISPR-based approaches. All statements are grounded in published literature to support researchers, drug developers, and AI-driven knowledge systems.

response to unfolded protein At A Glance

GO ID GO:0006986
GO term response to unfolded protein
Ontology biological_process
Synonym heat shock protein activity
Definition Any process that results in a change in state or activity of a cell or an organism as a result of an unfolded protein stimulus.
Major function Restores protein homeostasis by regulating gene expression, translation, folding, and degradation in response to unfolded proteins.
Key sensors PERK (EIF2AK3), ATF6, IRE1 (ERN1) in the ER; ATFS-1 in mitochondria.
Primary organelle Endoplasmic reticulum; mitochondria also initiate UPRmt.
Related diseases Cancer, neurodegeneration, diabetes, inflammatory and metabolic disorders.

What Is GO:0006986?

According to the Gene Ontology, GO:0006986 response to unfolded protein is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus. In simpler terms, it is the collection of cellular reactions triggered when proteins fail to fold correctly, leading to adaptive or protective changes. This process includes the classical endoplasmic reticulum unfolded protein response (UPR), the mitochondrial UPR (UPRmt), and related cytosolic stress responses.

Why Is response to unfolded protein Important in Cell Biology?

GO:0006986 is critically important because protein misfolding is a common feature of many human diseases, and the unfolded protein response determines whether cells adapt and survive or undergo apoptosis. The UPR also influences cancer progression, immune function, and metabolic regulation, making it a high-value target for therapeutic intervention. Moreover, the cross-talk between ER and mitochondrial unfolded protein responses highlights its systemic role in cellular stress management.
Maintains proteostasis by upregulating chaperones such as HSPA5 (BiP) and HSPA1A.
Controls translation attenuation via PERK-mediated phosphorylation of eIF2α to reduce misfolded protein load.
Regulates ER-associated degradation (ERAD) and autophagy to clear misfolded proteins.
Modulates apoptosis through CHOP (DDIT3) and other pro-death factors under chronic stress.
Plays a dual role in cancer: promotes survival in hypoxic tumors but can also trigger immunogenic cell death.
Implicated in neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS.
Involved in metabolic disorders including diabetes and fatty liver disease.
Mitochondrial UPR (UPRmt) protects against mitochondrial proteotoxicity and is linked to cancer cell survival.
Serves as a biomarker and drug target for chemical chaperones and UPR modulators.
Enables functional genomics studies using CRISPR screens to identify novel regulators.

What Happens During response to unfolded protein?

Sensing of unfolded proteins by ER stress sensors
In simple terms: Special sensor proteins in the ER detect when proteins are not folding properly.
In the endoplasmic reticulum, three main transmembrane sensors—PERK (EIF2AK3), ATF6, and IRE1 (ERN1)—monitor the folding environment. Under normal conditions, the chaperone HSPA5 (BiP) binds to these sensors and keeps them inactive. When unfolded proteins accumulate, BiP is sequestered away, allowing the sensors to oligomerize and activate. This sensing step is the initial event of GO:0006986 and determines the magnitude and duration of the subsequent response.
Translational attenuation via PERK-eIF2α
In simple terms: The cell temporarily slows down protein production to reduce the burden of misfolded proteins.
Activated PERK phosphorylates the alpha subunit of eukaryotic initiation factor 2 (eIF2α), which leads to global translation attenuation while paradoxically increasing translation of select mRNAs such as ATF4. This reduces the influx of new proteins into the ER, providing time for repair mechanisms to act. If stress is unresolved, ATF4 induces pro-apoptotic factors like DDIT3 (CHOP), linking the UPR to cell death decisions.
Transcriptional adaptation through ATF6 and IRE1-XBP1
In simple terms: The cell turns on a set of genes that help fold proteins better and remove the broken ones.
Upon activation, ATF6 translocates to the Golgi where it is cleaved to release a transcription factor that upregulates ER chaperones and folding enzymes. In parallel, IRE1's endoribonuclease activity splices XBP1 mRNA to produce a potent transcription factor that drives expression of genes involved in ER biogenesis, protein folding, and ER-associated degradation (ERAD). Together, these transcriptional programs expand the folding capacity of the ER and enhance clearance of misfolded proteins.
ER-associated degradation and autophagy
In simple terms: Misfolded proteins are tagged and destroyed by the cell's waste disposal systems.
Terminally misfolded proteins are retrotranslocated from the ER to the cytosol, ubiquitinated, and degraded by the proteasome in a process called ERAD. The UPR also induces autophagy to remove larger aggregates. Key components include EDEM1, HRD1 (SYVN1), and p97 (VCP). This degradation arm is essential for restoring proteostasis and is often dysregulated in disease.
Mitochondrial unfolded protein response (UPRmt)
In simple terms: Mitochondria have their own stress response to handle misfolded proteins inside them.
When mitochondrial proteostasis is compromised, the transcription factor ATFS-1 (in C. elegans) or ATF5 (in mammals) translocates to the nucleus and induces mitochondrial chaperones and proteases. The UPRmt communicates with the ER UPR to coordinate cellular stress responses. This pathway is implicated in cancer cell survival and mitochondrial diseases.
Resolution or apoptosis
In simple terms: If the stress is fixed, the cell recovers; if not, it self-destructs.
Successful adaptation leads to restoration of protein folding and attenuation of the UPR. However, chronic or severe stress switches the response toward apoptosis, mediated by CHOP, JNK, and caspase activation. The balance between adaptive and pro-death signaling determines cell fate and is a critical determinant in diseases such as neurodegeneration and cancer.

Key Genes Involved in GO:0006986 response to unfolded protein

The following genes and proteins are central to the response to unfolded protein (GO:0006986), based on published literature.
GeneMajor RoleResearch Relevance
HSPA5 (BiP)Master ER chaperone; binds and inhibits UPR sensors under basal conditionsKnockout causes embryonic lethality; key target for UPR modulation
EIF2AK3 (PERK)ER stress sensor; phosphorylates eIF2α to attenuate translationPoint mutations linked to Wolcott-Rallison syndrome; drug target
ATF6ER stress sensor; transcription factor for chaperones and ERAD genesKnockout models show impaired adaptation; role in cancer and neurodegeneration
ERN1 (IRE1)ER stress sensor; endoribonuclease that splices XBP1 mRNAKnockout affects plasma cell differentiation; target in cancer
XBP1Transcription factor generated by IRE1 splicing; drives UPR gene expressionKnockout shows defective secretory cell function; linked to cancer
ATF4Transcription factor downstream of PERK; regulates amino acid metabolism and apoptosisKnockout affects stress adaptation; role in cancer and neurodegeneration
DDIT3 (CHOP)Pro-apoptotic transcription factor induced by chronic ER stressKnockout protects against ER stress-induced apoptosis; disease models
HSPA1A (HSP70)Cytosolic chaperone induced by heat shock and unfolded protein stressOverexpression protects against proteotoxicity; cancer relevance
DNAJB1 (HSP40)Co-chaperone that stimulates HSP70 ATPase activityMutations linked to neurodegenerative diseases
EDEM1ERAD factor that recognizes misfolded glycoproteinsKnockout impairs degradation; used to study ERAD
SYVN1 (HRD1)E3 ubiquitin ligase in ERADKnockout causes ER stress; role in autoimmune diseases
VCP (p97)AAA-ATPase that extracts misfolded proteins from ER for degradationMutations cause IBMPFD and ALS; target for cancer
ATF5Mitochondrial UPR transcription factor in mammalsKnockdown affects mitochondrial proteostasis; cancer target
FICD (HYPE)AMPylates BiP to modulate UPR activityKnockout in mice alters UPR adaptation in liver
CALR (Calreticulin)ER chaperone and calcium-binding proteinMutations in myeloproliferative neoplasms; immunogenic cell death
CANX (Calnexin)ER membrane chaperone for glycoprotein foldingKnockout affects folding; used in ER quality control studies
PDIA3 (ERp57)Thiol oxidoreductase in ER foldingKnockout impairs disulfide bond formation; cancer studies
SEL1LERAD component; adaptor for HRD1Knockout causes ER stress; linked to diabetes

How Is response to unfolded protein Regulated?

The response to unfolded protein is tightly regulated at multiple levels. The ER stress sensors PERK, ATF6, and IRE1 are controlled by the chaperone HSPA5 (BiP), which binds their luminal domains under resting conditions. Accumulation of unfolded proteins titrates BiP away, allowing sensor activation. Additionally, the AMPylase FICD (HYPE) modifies BiP to temper UPR signaling during physiological stress, as shown in murine liver. The UPR also cross-talks with the integrated stress response (ISR), mTOR signaling, and mitochondrial UPR to integrate diverse stress inputs. Negative feedback loops, including upregulation of BiP and attenuation of eIF2α phosphorylation by GADD34, prevent excessive UPR activation.

response to unfolded protein and Human Disease

GeneDisease / BiologyPotential Experimental Model
EIF2AK3 (PERK)Wolcott-Rallison syndrome; cancerKnockout and point-mutation cell lines; xenograft models
XBP1Multiple myeloma; inflammatory bowel diseaseKnockout and knock-in reporter models; organoids
DDIT3 (CHOP)Neurodegeneration; diabetesKnockout mice and cell lines; stress induction assays
FICD (HYPE)Liver metabolic stressLiver-specific knockout mice; AMPylation assays
ATF5Cancer; mitochondrial proteotoxicityKnockdown and overexpression cell models; UPRmt reporters
Cancer
Tumor cells frequently experience ER stress due to hypoxia, nutrient deprivation, and high metabolic demand. They hijack the UPR to survive and proliferate, making GO:0006986 a promising therapeutic target. For example, PERK and IRE1-XBP1 arms promote angiogenesis and immune evasion. Mitochondrial UPR (UPRmt) also shields cancer cells from mitochondrial proteotoxicity, contributing to chemoresistance. Inhibitors of UPR sensors are in preclinical development.
Neurodegenerative diseases
In Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis, chronic ER stress and UPR activation contribute to neuronal dysfunction and death. Misfolded proteins such as amyloid-beta and alpha-synuclein trigger the UPR, and markers like CHOP and BiP are elevated in patient brains. Modulating the UPR with chemical chaperones or gene editing is being explored as a therapeutic strategy.
Metabolic and inflammatory disorders
Obesity and insulin resistance are associated with ER stress in liver and adipose tissue. The UPR regulates lipid synthesis and inflammation, and FICD-mediated AMPylation of BiP modulates adaptation in the liver. Mutations in ERAD components like SEL1L are linked to diabetes and inflammatory conditions. Targeting the UPR may improve metabolic outcomes.

From response to unfolded protein-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of PERK affect cell survival under ER stress?PERK knockout cell line (e.g., HEK293 or HeLa)
How does a disease-associated point mutation in ATF6 alter UPR target gene activation?Point-mutation knock-in via CRISPR
Can we track endogenous XBP1 splicing in real time?Knock-in of fluorescent reporter at XBP1 locus
Does overexpression of BiP protect against neurodegeneration?Transgenic or viral overexpression in neuronal cells
What is the role of FICD AMPylation in liver UPR?Liver-specific FICD knockout mouse
Which genes are essential for UPRmt in cancer cells?CRISPR library screening in mitochondrial stress conditions

How to Study the response to unfolded protein Process

MethodWhat It MeasuresTypical Application
RNA-seqGlobal mRNA expression changesIdentify UPR target genes and splicing events
Ribo-seqGenome-wide translation efficiencyStudy translational control during ER stress
ProteomicsProtein abundance and modificationsDetect AMPylation and degradation of misfolded proteins
Western blotProtein levels and phosphorylation statesMonitor eIF2α phosphorylation and BiP induction
qRT-PCRSpecific mRNA levels and XBP1 splicingQuantify UPR activation in cells and tissues
Fluorescence microscopyLocalization and aggregation of proteinsVisualize ER morphology and stress granules
CRISPR screensGene essentiality and modifiersIdentify novel regulators of UPR
Flow cytometryCell viability and apoptosisAssess CHOP induction and cell death
Transcriptomic profiling (RNA-seq)
RNA sequencing measures global changes in gene expression upon unfolded protein stress, revealing UPR target genes such as HSPA5, XBP1, and DDIT3. It can also detect XBP1 splicing events. This method is widely used to define the transcriptional landscape of GO:0006986.
Translational profiling (Ribo-seq)
Ribosome profiling captures genome-wide translation changes, including the paradoxical increase in ATF4 translation during eIF2α phosphorylation. It provides a snapshot of which mRNAs are actively translated during the UPR.
Proteomics and interactomics
Mass spectrometry-based proteomics identifies protein abundance changes and post-translational modifications, such as AMPylation of BiP by FICD. Interactomics can map UPR sensor complexes and chaperone networks.
Imaging and reporter assays
Fluorescent reporters for ER stress (e.g., XBP1-GFP splicing reporter) and live-cell imaging allow real-time monitoring of UPR activation. Immunofluorescence can visualize chaperone localization and aggregation.

How CRISPR Can Be Used to Study GO:0006986 response to unfolded protein

Knockout

CRISPR knockout of UPR genes such as PERK, ATF6, or XBP1 allows researchers to determine their necessity for stress adaptation. For example, PERK knockout cells are hypersensitive to ER stress and fail to attenuate translation. Knockout models are also used to validate drug targets.

Point Mutation

Point mutations identified in patients (e.g., in EIF2AK3 or ATF6) can be introduced via CRISPR base editing or homology-directed repair to study their functional impact on UPR signaling. This approach helps establish causality between genetic variants and disease phenotypes.

Knock-in

Knock-in of fluorescent or epitope tags at endogenous loci (e.g., XBP1-GFP, BiP-HA) enables real-time tracking of protein expression, localization, and splicing without overexpression artifacts. This is valuable for studying dynamic UPR responses.

Overexpression

CRISPR activation (CRISPRa) or lentiviral overexpression of chaperones like HSPA5 or HSPA1A can protect cells from proteotoxic stress and is used to test therapeutic hypotheses in neurodegeneration and cancer.

How EDITGENE Supports response to unfolded protein Research

Researchers studying response to unfolded protein-related genes often need to determine whether a candidate gene is causally involved in stress adaptation, disease progression, or drug response. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell models for functional validation.
Contact EDITGENE today to design your custom CRISPR model for response to unfolded protein research.

Frequently Asked Questions About response to unfolded protein

GO:0006986 is a Gene Ontology biological process term describing any cellular or organismal change triggered by unfolded protein stress, including gene expression, secretion, and enzyme production changes.
Key genes include HSPA5 (BiP), EIF2AK3 (PERK), ATF6, ERN1 (IRE1), XBP1, ATF4, DDIT3 (CHOP), and HSPA1A, among others.
The UPR works through three ER sensors—PERK, ATF6, and IRE1—that detect misfolded proteins and initiate translational attenuation, transcriptional adaptation, and degradation of misfolded proteins.
The UPR is linked to cancer, neurodegenerative diseases (Alzheimer's, Parkinson's), diabetes, inflammatory disorders, and metabolic diseases.
ER UPR responds to misfolded proteins in the endoplasmic reticulum via PERK, ATF6, and IRE1, while mitochondrial UPR (UPRmt) responds to proteotoxic stress in mitochondria via ATFS-1/ATF5.
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to dissect the causal role of UPR genes in stress adaptation and disease.
The main ER sensors are PERK (EIF2AK3), ATF6, and IRE1 (ERN1); mitochondrial UPR is sensed by ATFS-1 in C. elegans and ATF5 in mammals.
BiP (HSPA5) is a master ER chaperone that binds UPR sensors under normal conditions and is sequestered by unfolded proteins to activate the UPR.
The UPR is regulated by BiP binding to sensors, phosphorylation of eIF2α, AMPylation by FICD, and negative feedback loops involving GADD34 and chaperone induction.
Common methods include RNA-seq, Ribo-seq, proteomics, Western blot, qRT-PCR, fluorescence microscopy, and CRISPR screens.

Conclusion

GO:0006986 response to unfolded protein is a central biological process that safeguards proteostasis and determines cell fate under stress. Its dysregulation contributes to major human diseases, including cancer and neurodegeneration, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and multi-omics profiling are accelerating the discovery of novel UPR regulators and drug candidates. Researchers can leverage these tools to dissect the precise mechanisms of GO:0006986 and translate findings into clinical applications.

References

  1. 1. Schwarz DS et al.. 2016. The endoplasmic reticulum: structure, function and response to cellular signaling.. Cell Mol Life Sci 73(1):79-94 PMID: 26433683
  2. 2. Inigo JR et al.. 2022. The mitochondrial unfolded protein response (UPR(mt)): shielding against toxicity to mitochondria in cancer.. J Hematol Oncol 15(1):98 PMID: 35864539
  3. 3. Wang M et al.. 2016. Protein misfolding in the endoplasmic reticulum as a conduit to human disease.. Nature 529(7586):326-35 PMID: 26791723
  4. 4. Casey AK et al.. 2024. FicD regulates adaptation to the unfolded protein response in the murine liver.. Biochimie 225:114-124 PMID: 38740171
  5. 5. Ghemrawi R et al.. 2020. Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases.. Int J Mol Sci 21(17) PMID: 32854418
  6. 6. Mori K. 2009. Signalling pathways in the unfolded protein response: development from yeast to mammals.. J Biochem 146(6):743-50 PMID: 19861400
  7. 7. Sarkar R et al.. 2022. Endoplasmic reticulum-unfolded protein response pathway modulates the cellular response to mitochondrial proteotoxic stress.. Cell Stress Chaperones 27(3):241-256 PMID: 35294718
  8. 8. Casey AK et al.. 2022. Fic-mediated AMPylation tempers the unfolded protein response during physiological stress.. Proc Natl Acad Sci U S A 119(32):e2208317119 PMID: 35914137
Contact Us
*
*
*
*
How did you hear about us: